Grade 4 oral mucositis and prolonged pancytopenia with high dose intravenous methotrexate in a patient of philadelphia positive acute lymphoblastic leukemia
Journal: International Journal of Basic & Clinical Pharmacology (Vol.1, No. 1)Publication Date: 2012-08-01
Authors : Vidisha M. Shah Dimple S. Mehta;
Page : 36-38
Keywords : Methotrexate (MTX); Mucositis; Pancytopenia; ALL;
Abstract
Antimetabolite drugs are rarely associated with grade 3 or 4 mucositis. However specific side effects such as bone marrow suppression, pancytopenia, hospitalization, high cost limit the use of intravenous methotrexate. Here we report a case of 25-year-old girl patient with Acute Lymphoblastic Leukemia (ALL) treated with 24 hour methotrexate in her continuous phase of chemotherapy. After 12 hours of completing the treatment she developed oral mucosal pain & she was not able to speak. After a week, her White Blood Cell (WBC) count was 600/cumm with fever and she could not speak and eat or drink. So she was hospitalized for few days till she can drink something. We report high grade mucositis with methotrexate. Hematologists should be aware of this possible side effect to undertake early intervention.
Other Latest Articles
- A study to evaluate the clinical outcome of drug-eluting vs. bare-metal stents for acute coronary syndrome patients during commercial use in real setting
- Current scenario of rational usage of various drugs in indoor patients
- To study the antihyperglycaemic and lipid lowering effect of garlic as an adjunct to metformin in patients of type 2 diabetes mellitus with obesity
- Approval of antineoplastic agents in India: comparison with the US and EU regions
- Small size sampling
Last modified: 2012-09-02 00:06:44